|
|
- 2018
Bevacizumab or laser for aggressive posterior retinopathy of prematurityKeywords: Aggressive posterior retinopathy of prematurity, bevacizumab, retinopathy of prematurity, treatment completion laser Abstract: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP)
|
